Industry First in 3D Printing Launched by DeGen Medical
DeGen Medical, Inc., which is a spinal implant manufacturer that primarily focuses on Patient Specific Solutions and Augmented Reality, recently announced their commercial launch of Impulse AM™, a porous titanium implant printed in 3D and designed for posterior interbody fusion, and is the first 3D printed spinal implant of its kind to use a different form of titanium material (namely Puri-Ti™) in conjunction with a proprietary process of manufacturing.
Craig Black, who is the founder of DeGen Medical and its CEO, said:
“After researching the traditional material and post processing methods, we identified a number of pitfalls that can cause sterility issues and device breakage. We brought the entire process in house while creating our own unique material composition and building method. As a result, we now have a clear pathway to deliver patient specific implants with minimal lead time at a reasonable cost.”
Impulse AM™ is the first interbody device to be added to DeGen’s 3D printed portfolio, and the product release supplies implants and instrumentation that has been designed for posterior lumbar interbody fusion and transforaminal lumbar interbody fusion. It comes in a variation of sizes and is designed to accommodate a broad range of patieent anatomies.
One highlight of the technology is the Proprietary “Green” Manufacturing Process. This means that at no point during the manufacturing process are cutting oils, heat treatment or fluids are required, which when produced with the Puri-Ti™ proprietary material means that the entire manufacturing process is “green”, and will make lead times shorter for patient-specific implants. Perfecting the chemistry and laser parameters needed to create the material used by Puri-Ti™ took 3 years, and DeGen Medical is the first company which has pioneered a game-changing material and manufacturing process within the medical device additive production space.
Another highlight are patient specific implants, which DeGen Medical will have the capability of creating in a fraction of the time and at a much lower cost. The products currently available on the market are used used sparingly, and are not usually part of the process in regular surgical interventions, however the company intends on changing this to become a leader of the market in patient-specific solutions.
© DeGen Medical Inc